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Background
Plasmodium knowlesi (Pk), a simian malaria parasite, is a
suitable primate model for Plasmodium falciparum (Pf),
and it was recently identified as the fifth human malaria
parasite [1]. To test the ability of yeast-expressed
PkAMA1 (Figure 1) to protect rhesus macaques upon
challenge with Pk, six healthy rhesus monkeys were
vaccinated with PkAMA1 and six control monkeys were
vaccinated with PfAMA1 formulated in an oil in water
adjuvant [2]. All monkeys received three i.m. vaccinations
at 4 week intervals.
Results
PkAMA1 monkeys produced antibodies that inhibited Pk
growth in vitro. Monkeys were challenged two weeks
after the third vaccination with Pk blood stage parasites
and parasitaemia was followed for 3 weeks. Five out of
six controls and one PkAMA1 animal developed fulmi-
nent parasitaemias. Four out of six PkAMA1 vaccinated
monkeys delayed the onset of the parasitaemia (> 2 days)
and one animal in the PkAMA1 group was able to com-
pletely control parasitaemia, which correlated with the
level of parasite growth inhibitory antibodies. PkAMA1
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vaccination delayed the rate of parasite development, but
no apparent sterile protection was achieved (Figure 1).
All animals were treated with chloroquine and left to
recover, and were subsequently boosted with PkAMA1
or PfAMA1 and challenged two weeks later with Pk
blood stage parasites and parasitaemia was followed for
5 weeks. All control animals became parasitaemic and
four out of six animals in the PkAMA1 group were able
to control the parasitaemia (<1.5%) and subsequently
clear the parasites to levels undetectable (Figure 2).
Conclusion
Protection from Pk challenge is possible albeit non-steri-
lising. GIA correlates with protection, IgG levels do not
at first challenge. Protection improves after challenge-
boost. The findings presented here may have implica-
tions for Pf challenge models in humans.
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